Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), PDGFR antagonists(Platelet-derived growth factor receptor antagonists), SCF inhibitors(KIT ligand inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H12N4S |
InChIKeyZGDACLBJJXLKJY-UHFFFAOYSA-N |
CAS Registry226717-28-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IL | 01 May 2003 |